12V.F
Veracyte, Inc.
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
35.59
▲ 0.34 (0.96%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
35.59
Prev close
35.25
Day high
35.59
Day low
35.59
Volume
100
Market cap
$2.86B
P/E (TTM)
29.66
52W range
24.40 – 52.72
Day trading desk
Gap from prior close
+0.96%
Prior close 35.25
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
—
35.59 – 35.59
Position in range
—
—
ATR (14D)
0.85
2.38% of price
Prior day high
35.25
PDH
Prior day low
35.25
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 5
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.08%
+2.3%
1M
-28.85%
-32.1%
3M
-5.24%
-7.6%
6M
+17.85%
+6.0%
YTD
-1.69%
-13.6%
1Y
+35.84%
+15.8%
3Y
+47.07%
-27.8%
5Y
-13.62%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 12V.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
431.70K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 18, 26 | EASTHAM KARIN Director |
SELL | 3.73K | $197.23K | Direct |
| Jun 11, 26 | EASTHAM KARIN Director |
STOCK | 5.27K | $0 | Direct |
| Jun 11, 26 | JONES EVAN Director |
STOCK | 5.27K | $0 | Direct |
| Jun 11, 26 | EPSTEIN ROBERT S Director |
STOCK | 5.27K | $0 | Direct |
| Jun 11, 26 | SHAFER DAVID BRENT Director |
STOCK | 5.27K | $0 | Direct |
| Jun 11, 26 | HOLSTEIN JENS Director |
STOCK | 5.27K | $0 | Direct |
| Jun 11, 26 | BHANJI MUNA Director |
STOCK | 5.27K | $0 | Direct |
| Jun 11, 26 | BARR ELIAV Director |
STOCK | 5.27K | $0 | Direct |
| Jun 11, 26 | MILLER THOMAS F Director |
STOCK | 5.27K | $0 | Direct |
| Jun 4, 26 | STAPLEY MARC A Chief Executive Officer |
SELL | 138.05K | $6.92M | Direct |
| Jun 4, 26 | CHAMBERS REBECCA Chief Financial Officer |
SELL | 3.56K | $177.08K | Direct |
| Jun 4, 26 | MCGUIRE ANNIE General Counsel |
SELL | 3.18K | $158.04K | Direct |
| Jun 4, 26 | LEITE JOHN Officer |
SELL | 13.97K | $699.73K | Direct |
| Jun 4, 26 | STAPLEY MARC A Chief Executive Officer |
CONVERSION | 138.05K | $5.05M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BARR ELIAV |
Director | 56.46K | Stock Award(Grant) |
BHANJI MUNA |
Director | 44.58K | Stock Award(Grant) |
CHAMBERS REBECCA |
Chief Financial Officer | 173.28K | Sale |
EPSTEIN ROBERT S |
Director | 57.72K | Stock Award(Grant) |
FEBBO PHILLIP G |
Officer | 153.53K | Stock Award(Grant) |
HAAS KEVIN RICHARD |
Officer | 44.22K | Stock Award(Grant) |
LEITE JOHN |
Officer | 132.31K | Sale |
MCGUIRE ANNIE |
General Counsel | 137.24K | Sale |
STAPLEY MARC A |
Chief Executive Officer | 440.49K | Sale |
WYGANT JONATHAN |
Officer | 45.43K | Sale |
Fundamentals
Market cap$2.86B
Enterprise value$2.39B
Revenue (TTM)$561.90M
Gross profit$414.44M
EBITDA$113.52M
Net income$114.48M
EPS (TTM)$1.20
Free cash flow$106.23M
Total cash$485.23M
Total debt$40.11M
Book value / share$14.79
Shares outstanding80.39M
Float79.88M
Short % of float—
Dividend yield—
Beta (5Y)1.94
Valuation & profitability ratios
Trailing P/E29.66
Forward P/E-69.78
PEG ratio—
Price / sales—
Price / book2.41
EV / revenue4.25
EV / EBITDA21.04
Gross margin73.76%
Operating margin15.29%
Profit margin20.37%
Return on equity8.77%
Return on assets4.09%
Debt / equity2.89
Current ratio9.16
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $517.14M | $445.76M | $361.05M | $296.54M | +16.0% |
| Operating revenue | $517.14M | $445.76M | $361.05M | $296.54M | +16.0% |
| Cost of revenue | $154.61M | $147.62M | $131.37M | $120.86M | +4.7% |
| Gross profit | $362.53M | $298.14M | $229.68M | $175.68M | +21.6% |
| Research & development | $70.81M | $69.29M | $57.30M | $40.60M | +2.2% |
| Selling, general & admin | $210.95M | $206.04M | $187.72M | $170.76M | +2.4% |
| Total operating expense | $284.25M | $278.63M | $247.13M | $211.02M | +2.0% |
| Operating income | $78.28M | $19.51M | -$17.45M | -$35.34M | +301.2% |
| Net interest income | $12.72M | $11.15M | $7.33M | $1.77M | +14.1% |
| Pre-tax income | $68.20M | $25.74M | -$76.61M | -$36.43M | +164.9% |
| Tax provision | $1.85M | $1.61M | -$2.21M | $133.00K | +15.1% |
| Net income | $66.35M | $24.14M | -$74.40M | -$36.56M | +174.9% |
| Net income to common | $66.35M | $24.14M | -$74.40M | -$36.56M | +174.9% |
| Basic EPS | 0.84 | 0.32 | -1.02 | -0.51 | +162.5% |
| Diluted EPS | 0.82 | 0.31 | -1.02 | -0.51 | +164.5% |
| EBIT | $68.20M | $25.75M | -$76.60M | -$36.23M | +164.9% |
| EBITDA | $89.62M | $49.20M | -$49.41M | -$10.30M | +82.1% |
| Basic shares | 78.58M | 76.48M | 72.64M | 71.55M | +2.7% |
| Diluted shares | 80.57M | 78.16M | 72.64M | 71.55M | +3.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $362.58M | $239.09M | $216.45M | $154.25M | — | +51.7% |
| Cash & short-term investments | $412.89M | $289.44M | $216.45M | $178.85M | — | +42.7% |
| Accounts receivable | $44.66M | $46.52M | $40.38M | $44.02M | — | -4.0% |
| Inventory | $20.55M | $21.75M | $16.13M | $14.29M | — | -5.5% |
| Total current assets | $488.38M | $372.27M | $285.62M | $248.64M | — | +31.2% |
| Property, plant & equipment | $58.79M | $71.14M | $30.86M | $30.86M | — | -17.4% |
| Goodwill & intangibles | $856.30M | $848.10M | $791.58M | $870.76M | — | +1.0% |
| Total assets | $1.41B | $1.30B | $1.11B | $1.16B | — | +8.2% |
| Total current liabilities | $59.94M | $78.63M | $61.24M | $62.61M | — | -23.8% |
| Current debt | — | — | — | — | $1.13M | — |
| Total debt | $39.65M | $50.74M | $12.63M | $14.72M | — | -21.8% |
| Total liabilities | $96.44M | $124.07M | $70.80M | $81.22M | — | -22.3% |
| Retained earnings | -$377.63M | -$443.98M | -$468.12M | -$393.72M | — | +14.9% |
| Shareholder equity | $1.31B | $1.18B | $1.04B | $1.08B | — | +11.4% |
| Working capital | $428.44M | $293.63M | $224.38M | $186.02M | — | +45.9% |
| Net tangible assets | $453.27M | $327.87M | $252.53M | $204.44M | — | +38.3% |
| Shares issued | 79.36M | 77.77M | 73.26M | 71.96M | — | +2.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $66.35M | $24.14M | -$74.40M | -$36.56M | +174.9% |
| Depreciation & amortisation | $21.41M | $23.46M | $27.19M | $25.93M | -8.7% |
| Stock-based compensation | $43.60M | $36.25M | $33.14M | $26.73M | +20.3% |
| Change in working capital | -$2.30M | -$20.96M | -$3.69M | -$16.38M | +89.0% |
| Operating cash flow | $136.31M | $75.10M | $44.22M | $7.54M | +81.5% |
| Capital expenditure | -$9.68M | -$11.29M | -$9.96M | -$8.55M | +14.3% |
| Investing cash flow | -$9.21M | -$56.27M | $15.11M | -$29.39M | +83.6% |
| Financing cash flow | -$4.22M | $4.90M | $2.84M | $3.49M | -186.1% |
| Free cash flow | $126.63M | $63.81M | $34.26M | -$1.01M | +98.5% |
| End cash position | $364.23M | $240.63M | $217.33M | $155.00M | +51.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $150.32M | $139.07M | $140.64M | $131.87M | $130.16M | — | +8.1% |
| Operating revenue | $150.32M | $139.07M | $140.64M | $131.87M | $130.16M | — | +8.1% |
| Cost of revenue | $41.77M | $37.91M | $38.66M | $40.59M | $40.40M | — | +10.2% |
| Gross profit | $108.55M | $101.16M | $101.97M | $91.28M | $89.77M | — | +7.3% |
| Research & development | $29.44M | $27.10M | $20.85M | $15.98M | $16.26M | — | +8.7% |
| Selling, general & admin | $55.71M | $50.84M | $43.47M | $50.71M | $57.65M | — | +9.6% |
| Total operating expense | $85.57M | $78.51M | $62.06M | $68.17M | $74.53M | — | +9.0% |
| Operating income | $22.98M | $22.65M | $39.91M | $23.11M | $15.24M | — | +1.5% |
| Net interest income | $3.88M | $3.48M | $3.54M | $3.48M | $2.94M | — | +11.7% |
| Pre-tax income | $26.52M | $29.97M | $40.63M | $18.89M | $1.25M | — | -11.5% |
| Tax provision | $1.03M | $1.27M | -$515.00K | -$248.00K | $2.23M | — | -18.5% |
| Net income | $25.49M | $28.71M | $41.15M | $19.14M | -$980.00K | — | -11.2% |
| Net income to common | $25.49M | $28.71M | $41.15M | $19.14M | -$980.00K | — | -11.2% |
| Basic EPS | 0.32 | 0.36 | 0.52 | — | -0.01 | 0.09 | -11.1% |
| Diluted EPS | 0.31 | 0.35 | 0.51 | — | -0.01 | 0.09 | -11.4% |
| EBIT | $26.52M | $29.97M | $40.63M | $18.89M | $1.25M | — | -11.5% |
| EBITDA | $31.36M | $35.40M | $45.93M | $24.16M | $6.74M | — | -11.4% |
| Basic shares | 79.97M | 79.54M | 79.18M | — | 78.39M | 78.03M | +0.5% |
| Diluted shares | 82.06M | 81.31M | 81.39M | — | 78.39M | 80.06M | +0.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $299.52M | $263.14M | $362.58M | $315.57M | $219.50M | +13.8% |
| Cash & short-term investments | $485.23M | $439.06M | $412.89M | $366.43M | $320.72M | +10.5% |
| Accounts receivable | $54.18M | $50.11M | $44.66M | $47.83M | $50.81M | +8.1% |
| Inventory | $22.66M | $21.42M | $20.55M | $20.33M | $25.02M | +5.8% |
| Total current assets | $574.77M | $522.17M | $488.38M | $449.22M | $414.68M | +10.1% |
| Property, plant & equipment | $57.10M | $58.52M | $58.79M | $56.20M | $57.23M | -2.4% |
| Goodwill & intangibles | $849.85M | $853.02M | $856.30M | $859.63M | $869.06M | -0.4% |
| Total assets | $1.49B | $1.44B | $1.41B | $1.37B | $1.34B | +3.5% |
| Total current liabilities | $62.74M | $56.12M | $59.94M | $72.15M | $76.43M | +11.8% |
| Total debt | $40.11M | $39.33M | $39.65M | $40.45M | $50.65M | +2.0% |
| Total liabilities | $97.96M | $91.99M | $96.44M | $110.12M | $123.05M | +6.5% |
| Retained earnings | -$323.43M | -$348.92M | -$377.63M | -$418.78M | -$437.92M | +7.3% |
| Shareholder equity | $1.39B | $1.34B | $1.31B | $1.26B | $1.22B | +3.3% |
| Working capital | $512.04M | $466.06M | $428.44M | $377.07M | $338.25M | +9.9% |
| Net tangible assets | $538.55M | $491.39M | $453.27M | $398.04M | $352.00M | +9.6% |
| Shares issued | 79.79M | 79.79M | 79.36M | 79.03M | 78.60M | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $25.49M | $28.71M | $41.15M | $19.14M | -$980.00K | -11.2% |
| Depreciation & amortisation | $4.84M | $5.43M | $5.30M | $5.27M | $5.49M | -10.9% |
| Stock-based compensation | $14.09M | $12.76M | $10.90M | $10.76M | $10.98M | +10.4% |
| Change in working capital | $1.74M | -$11.73M | $5.48M | $4.45M | $2.27M | +114.8% |
| Operating cash flow | $45.83M | $35.22M | $52.58M | $44.76M | $33.60M | +30.1% |
| Capital expenditure | -$2.86M | -$2.96M | -$3.78M | -$2.79M | -$1.29M | +3.5% |
| Investing cash flow | -$13.54M | -$127.96M | -$5.43M | $48.26M | -$224.00K | +89.4% |
| Financing cash flow | $4.14M | -$6.63M | -$149.00K | $2.98M | -$566.00K | +162.4% |
| Free cash flow | $42.97M | $32.25M | $48.80M | $41.97M | $32.32M | +33.2% |
| End cash position | $301.19M | $264.79M | $364.23M | $317.21M | $221.15M | +13.7% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $147.15M | +11.6% |
| Next quarter | — | — | $157.31M | +11.9% |
| Current year | — | — | $593.66M | +14.8% |
| Next year | — | — | $659.93M | +11.2% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.54%
Held by institutions113.45%
Institutions holding507
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
36.54
-2.61% from price
SMA 20
39.71
-10.39% from price
SMA 50
45.37
-21.56% from price
SMA 100
39.47
-9.83% from price
SMA 200
36.47
-2.40% from price
EMA 12
37.29
-4.56% from price
EMA 26
40.38
-11.86% from price
EMA 50
41.76
-14.78% from price
RSI (14)
32.0
Neutral
MACD (12,26,9)
-3.09
Hist -0.31
ATR (14)
0.85
2.38% of price
Realised vol 30D
63.4%
Annualised
Bollinger upper
48.71
20, 2σ
Bollinger lower
30.71
20, 2σ
50 / 200 cross
Golden
45.37 vs 36.47
Trend bias
Below 200
-2.40%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.34
Less volatile than market
Correlation to SPY
0.08
Largely independent
Realised vol 30D
63.4%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-38.7%
Peak to trough
Max drawdown 5Y
-68.8%
Peak to trough
ATR 14
0.85
2.38% of price
Beta (reported)
1.94
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 4, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Aug 4, 26 | Stephens & Co. | MAINTAINED | Overweight | Overweight |
| Aug 4, 26 | Morgan Stanley | MAINTAINED | Underweight | Underweight |
| Aug 3, 26 | Canaccord Genuity | MAINTAINED | Hold | Hold |
| Jul 31, 26 | Needham | MAINTAINED | Buy | Buy |
| Jul 30, 26 | Needham | MAINTAINED | Buy | Buy |
| Jul 15, 26 | Piper Sandler | INITIATED | Overweight | Overweight |
| Jul 14, 26 | Canaccord Genuity | MAINTAINED | Hold | Hold |
| Jul 9, 26 | Morgan Stanley | MAINTAINED | Underweight | Underweight |
| Jun 29, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Jun 1, 26 | Needham | MAINTAINED | Buy | Buy |
| May 28, 26 | Needham | MAINTAINED | Buy | Buy |
Headlines
IHCL to merge Oriental Hotels under proposed share-swap deal
Hotel Management Network · 4m ago
Houlihan Lokey (HLI): Buy, Sell, or Hold Post Q2 Earnings?
StockStory · 6m ago
LIVE: US unveils new sanctions on Iran
Yahoo Finance Video · 6m ago
CPK chooses T-ROC Global to deploy automated food kiosks
Verdict Food Service · 8m ago
Dunkin’ and BARK Unleash First-Ever Doggie Drive-Thru
QSR · 10m ago
XPENG Reports Q2 2026 Results: Gross Margin Reaches 20.7%, Overseas Market Drives 25% of H1 Revenue
PR Newswire · 10m ago
Cut Flowers Market Size to Reach $52.78 Billion by 2031 as Online Ordering and Cold-Chain Innovation Reshape Global Trade, Reports Mordor Intelligence
PR Newswire · 11m ago
Visy launches automated labelling system for fresh produce packs
Packaging Gateway · 12m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.